Q2 2026 saw 7.5% sales growth and a 28.9% rise in adjusted EPS, with strong segment performance and improved margins. A $94.4 million impairment charge impacted GAAP results, but the outlook for 2026 was raised, reflecting confidence in continued growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.